Cerenome, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
CNSY Nasdaq 2834 cerenome.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cerenome, Inc.

Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment - Sep 10th, 2026 5:15 am
Cerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business Lines - Aug 20th, 2026 5:30 am
Cerenome Reports Second Quarter 2026 Financial Results and Business Update - Aug 14th, 2026 2:15 pm
Cerenome Secures In-Network Agreement with Health Care Service Corporation, Expanding CNSide® Contracted Coverage to Over 150 Million Covered Lives - Aug 13th, 2026 5:30 am
Cerenome Selects XiFin Empower RCM for Revenue Cycle Management and Clearinghouse Services for CNSide Platform - Aug 6th, 2026 5:30 am
Cerenome Launches as an Integrated CNS Oncology Company - Jul 31st, 2026 6:30 am